Buprenorphine and naloxone interactions in opiate-dependent volunteers* (Q56764300)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689806%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

title

Buprenorphine and naloxone interactions in opiate-dependent volunteers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689806%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

author name string

Mendelson J

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689806%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

Jones RT

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689806%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

Fernandez I

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689806%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

Welm S

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689806%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

Melby AK

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689806%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

Baggott MJ

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689806%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

language of work or name

English

0 references

publication date

1 July 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689806%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

17 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689806%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689806%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689806%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

page(s)

105-114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689806%20AND%20SRC:MED&resulttype=core&format=json

Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine

17 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Plasma levels of opioid material in man following sublingual and intravenous administration of buprenorphine: exogenous/endogenous opioid interaction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Use of buprenorphine in the treatment of opiate addiction. I. Physiologic and behavioral effects during a rapid dose induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

A controlled trial of buprenorphine treatment for opioid dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Treatment of Heroin Addicts Using Buprenorphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Buprenorphine abuse among opiate addicts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Naloxone-induced withdrawal in patients with buprenorphine dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Buprenorphine abuse: report from India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Analysis of epidemiological data on agonist-antagonist analgesics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Buprenorphine and temazepam--abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

The use of buprenorphine and temazepam by drug injectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Buprenorphine and temazepam abuse by drug takers in Glasgow--an increase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Abuse of buprenorphine (Temgesic) by snorting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

After the epidemic: follow up study of HIV seroprevalence and changing patterns of drug use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Buprenorphine alone and in combination with naloxone in non-dependent humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Sublingual versus subcutaneous buprenorphine in opiate abusers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Sublingual buprenorphine as postoperative analgesic: a double-blind comparison with pethidine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Combined naloxone/methadone preparations for opiate substitution therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Opioid antagonist challenges in buprenorphine maintained patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Effects of buprenorphine and methadone in methadone-maintained subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

The naloxone test for opiate dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Levels of opioid physical dependence in heroin addicts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Assessment of opioid dependence with naloxone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

The quantitative assessment of physical dependence on opiates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Clinical pharmacology of narcotic antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3

Buprenorphine and naloxone alone and in combination in opioid-dependent humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990173-3